<H1>Chapter DOI: 10.1186/s12879-016-1587-y<br/>Cited-By Count: </H1><table border="1" width="30%"><tr><td>Total References</td><td>50</td></tr><tr><td>Springer references</td><td>1</td></tr><tr><td>Non Springer references</td><td>49</td></tr><tr><td>BibStructured Count</td><td width="10%">46</td></tr><tr><td>BibUnstructured Count</td><td width="10%">4</td></tr><tr><td>DOI already available in SpringerLink</td><td>33</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>0</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>1</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>1</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>1</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Diop OM, Burns CC, Wassilak SG, Kew OM. Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013. MMWR Morb Mortal Wkly Rep. 2014;63:242&#8211;8. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6311a5.htm. [Accessed 6 May 2016].</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Platt LR, Est&#237;variz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. J Infect Dis. 2014;210 Suppl:S380&#8211;9.</td><td><a href=http://dx.doi.org/10.1093/infdis/jiu184>10.1093/infdis/jiu184</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014;210(Suppl):S283&#8211;93.</td><td><a href=http://dx.doi.org/10.1093/infdis/jiu295>10.1093/infdis/jiu295</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>WHO. Classification of AFP cases, surveillance performance and weekly reporting by country to WHO European Regional Office, 2013&#8211;2014. In WHO EpiData. 2014;2014:6. http://www.euro.who.int/__data/assets/pdf_file/0004/262183/EpiData-8-2014.pdf. [Accessed 6 May 2016].</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med. 1994;148:479&#8211;85.</td><td><a href=http://dx.doi.org/10.1001/archpedi.1994.02170050037007>10.1001/archpedi.1994.02170050037007</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587&#8211;635.</td><td><a href=http://dx.doi.org/10.1146/annurev.micro.58.030603.123625>10.1146/annurev.micro.58.030603.123625</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Khetsuriani N, Prevots DR, Quick L, Elder ME, Pallansch M, Kew O, et al. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis. 2003;188:1845&#8211;52.</td><td><a href=http://dx.doi.org/10.1086/379791>10.1086/379791</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Mart&#237;n J. Vaccine-derived poliovirus from long term excretors and the end game of polio eradication. Biologicals. 2006;34:117&#8211;22.</td><td><a href=http://dx.doi.org/10.1016/j.biologicals.2006.02.005>10.1016/j.biologicals.2006.02.005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Alexander JP, Gary HE, Pallansch MA. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis. 1997;175(Suppl):S176&#8211;82.</td><td><a href=http://dx.doi.org/10.1093/infdis/175.Supplement_1.S176>10.1093/infdis/175.Supplement_1.S176</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Mart&#237;n J, Odoom K, Tuite G, Dunn G, Hopewell N, Cooper G, et al. Long-term excretion of vaccine-derived poliovirus by a healthy child. J Virol. 2004;78:13839&#8211;47.</td><td><a href=http://dx.doi.org/10.1128/JVI.78.24.13839-13847.2004>10.1128/JVI.78.24.13839-13847.2004</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Fiore</span> <span style='background:#DDDDDD'>L</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Buttinelli</span> <span style='background:#DDDDDD'>G</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Fiore</span> <span style='background:#DDDDDD'>S.</span></span>, <span style='background:#BDBAD6'>Acute flaccid paralysis surveillance and monitoring of circulation of polio and other enteroviruses in Italy. Roma Ist Super di Sanit&#224; Rapp ISTISAN 13/44</span></aug> <span style='background:#66FF66'>2013</span>. <span style='background:#FF3300'>http://www.iss.it/publ/index.php?id=2788&tipo=5&lang=1</span>. <span style='background:#FFFF0F'>[Accessed 6 May 2016]</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Fiore L, Novello F, Simeoni P, Amato C, Vellucci L, De Stefano D, et al. Surveillance of acute flaccid paralysis in Italy: 1996&#8211;97. Eur J Epidemiol. 1999;15:757&#8211;76.</td><td><a href=http://dx.doi.org/10.1023/A:1007697421114>10.1023/A:1007697421114</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Fiore L, Novello F, Simeoni P, Amato C, Buttinelli G, Fiore S, et al. Epidemiology of acute flaccid paralysis in Italy: 1996&#8211;98. Group for the Study of AFP. Ann Ig. 2000;12:99&#8211;110.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Patti AM, Santi AL, Vulcano A, Casagni L, Lamberti A, De Stefano CD, et al. Surveillance of poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results. Ann Ig. 2002;14(4 Suppl 5):1&#8211;57.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Minor PD. Biosafety consequences of eradication of wild-type polioviruses. Lancet. 2001;358:166&#8211;8.</td><td><a href=http://dx.doi.org/10.1016/S0140-6736(01)05399-5>10.1016/S0140-6736(01)05399-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Buttinelli G, Donati V, Fiore S, Marturano J, Plebani A, Balestri P, et al. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J Gen Virol. 2003;84:1215&#8211;21.</td><td><a href=http://dx.doi.org/10.1099/vir.0.18974-0>10.1099/vir.0.18974-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Fiore</span> <span style='background:#DDDDDD'>L</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Buttinelli</span> <span style='background:#DDDDDD'>G</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Fiore</span> <span style='background:#DDDDDD'>S.</span></span>, <span style='background:#BDBAD6'>Acute flaccid paralysis surveillance and monitoring of circulation of polio and other enteroviruses in Italy. ISTISAN Reports.</span></aug> <span style='background:#66FF66'>2013</span>;13/44:101 <span style='background:#FF3300'>http://www.iss.it/binary/publ/cont/13_44_web.pdf</span>. <span style='background:#FFFF0F'>[Accessed 6 May 2016]</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibBook</td><td>Siegel J, Rhinehart E, Jackson M, Chiarello L, the Healthcare Control Practices Advisory Committee. Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. 2007. http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf. [Accessed 6 May 2016].</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR19</td><td>BibUnstructured</td><td>WHO. Polio Laboratory Manual. WHO/IVB/04.10. Geneva, Switzerland: World Health Organization; <span style='background:#66FF66'>2004</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR20</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Hall</span> <span style='background:#DDDDDD'>TA</span></span></aug>. <span style='background:#FF9933'>BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT</span>. In: <span style='background:#FFD9B3'>Nucleic Acids Symposium Series</span>. Volume&amp;nbsp;<span style='background:#FFCC66'>41</span>. Ed. <span style='background:#C0FFC0'>New York, NY</span>: <span style='background:#FFFF49'>Oxford University Press</span>; <span style='background:#66FF66'>1999</span>. p.&amp;nbsp;<span style='background:#D279FF'>95&#8211;98</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10:845&#8211;58.</td><td><a href=http://dx.doi.org/10.1038/nprot.2015.053>10.1038/nprot.2015.053</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Fine PE, Carneiro IA. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am J Epidemiol. 1999;150:1001&#8211;21.</td><td><a href=http://dx.doi.org/10.1093/oxfordjournals.aje.a009924>10.1093/oxfordjournals.aje.a009924</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Macadam AJ, Ferguson G, Fleming T, Stone DM, Almond JW, Minor PD. Role for poliovirus protease 2A in cap independent translation. EMBO J. 1994;13:924&#8211;7.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Mart&#237;n J, Dunn G, Hull R, Patel V, Minor PD. Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol. 2000;74:3001&#8211;10.</td><td><a href=http://dx.doi.org/10.1128/JVI.74.7.3001-3010.2000>10.1128/JVI.74.7.3001-3010.2000</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M, et al. Determinants in the 5&#8217; noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol. 1989;63:1302&#8211;9.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Minor PD. The molecular biology of poliovaccines. J Gen Virol. 1992;73(12):3065&#8211;77.</td><td><a href=http://dx.doi.org/10.1099/0022-1317-73-12-3065>10.1099/0022-1317-73-12-3065</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Shahmahmoodi S, Parvaneh N, Burns C, Asghar H, Mamishi S, Tabatabaie H, et al. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. Virus Res. 2008;137:168&#8211;72.</td><td><a href=http://dx.doi.org/10.1016/j.virusres.2008.07.006>10.1016/j.virusres.2008.07.006</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Martinez CV, Old MO, Kwock DK, Khan SS, Garcia JJ, Chan CS, et al. Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine. J Infect Dis. 2004;190:409&#8211;16.</td><td><a href=http://dx.doi.org/10.1086/421703>10.1086/421703</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Filman DJ, Syed R, Chow M, Macadam AJ, Minor PD, Hogle JM. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 1989;8:1567&#8211;79.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.2210/pdb2plv/pdb>10.2210/pdb2plv/pdb</a></td><td><b>CrossRef-Web</b></td>
<td>Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Macadam AJ, Ferguson G, Arnold C, Minor PD. An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. J Virol. 1991;65:5225&#8211;31.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Nathanson N. David Bodian&#8217;s contribution to the development of poliovirus vaccine. Am J Epidemiol. 2005;161:207&#8211;12.</td><td><a href=http://dx.doi.org/10.1093/aje/kwi033>10.1093/aje/kwi033</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Shaghaghi M, Parvaneh N, Ostad-Rahimi P, Fathi SM, Shahmahmoodi S, Abolhassani H, et al. Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature. Immunol Invest. 2014;43:292&#8211;8.</td><td><a href=http://dx.doi.org/10.3109/08820139.2013.859156>10.3109/08820139.2013.859156</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Cammack N, Phillips A, Dunn G, Patel V, Minor PD. Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology. 1988;167:507&#8211;14.</td><td><a href=http://dx.doi.org/10.1016/S0042-6822(88)90113-4>10.1016/S0042-6822(88)90113-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Kew OM, Sutter RW, Nottay BK, McDonough MJ, Prevots DR, Quick L, et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol. 1998;10:2893&#8211;9.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Bellmunt A, May G, Zell R, Pring-Akerblom P, Verhagen W, Heim A. Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology. 1999;265:178&#8211;84.</td><td><a href=http://dx.doi.org/10.1006/viro.1999.0003>10.1006/viro.1999.0003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Dunn G, Klapsa D, Wilton T, Stone L, Minor PD, Martin J. Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative. PLoS Pathog. 2015;11(8):e1005114.</td><td><a href=http://dx.doi.org/10.1371/journal.ppat.1005114>10.1371/journal.ppat.1005114</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Guo J, Bolivar-Wagers S, Srinivas N, Holubar M, Maldonado Y. Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication. Vaccine. 2015;33(10):1235&#8211;42.</td><td><a href=http://dx.doi.org/10.1016/j.vaccine.2015.01.018>10.1016/j.vaccine.2015.01.018</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Li L, Ivanova O, Driss N, Tiongco-Recto M, da Silva R, Shahmahmoodi S, et al. Poliovirus Excretion Among Persons With Primary Immune Deficiency Disorders: Summary of a Seven-Country Study Series. J Infect Dis. 2014;210 Suppl 1:S368&#8211;72.</td><td><a href=http://dx.doi.org/10.1093/infdis/jiu065>10.1093/infdis/jiu065</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Morimoto N. The relationship between poliovirus multiplication, the sIgA antibody response and the serum neutralizing antibody titers after trivalent oral polio vaccination. Kansenshogaku Zasshi. 2001;75:1030&#8211;9.</td><td><a href=http://dx.doi.org/10.11150/kansenshogakuzasshi1970.75.1030>10.11150/kansenshogakuzasshi1970.75.1030</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Racaniello VR. One hundred years of poliovirus pathogenesis. Virology. 2006;344:9&#8211;16.</td><td><a href=http://dx.doi.org/10.1016/j.virol.2005.09.015>10.1016/j.virol.2005.09.015</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibChapter</td><td>Bodian D, Horstmann DH. Polioviruses. In: Horsfall FL, Tamm I, editors. Viral and Rickettsial Infections of Man. Philadelphia: Lippincott; 1965. p. 430&#8211;73.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Macadam AJ, Arnold C, Howlett J, John A, Marsden S, Taffs F, et al. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology. 1989;172:408&#8211;14.</td><td><a href=http://dx.doi.org/10.1016/0042-6822(89)90183-9>10.1016/0042-6822(89)90183-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Tatem JM, Weeks-Levy C, Georgiu A, DiMichele SJ, Gorgacz EJ, Racaniello VR, et al. A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J Virol. 1992;5:3194&#8211;7.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Gumede N, Muthambi V, Schoub BD. Immunodeficiency-associated vaccine-derived poliovirus type 3 in infant, South Africa, 2011. Emerg Infect Dis. 2012;18:992&#8211;4.</td><td><a href=http://dx.doi.org/10.3201/eid1806.120037>10.3201/eid1806.120037</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Battistone A, Buttinelli G, Fiore S, Amato C, Bonomo P, Patti AM, et al. Sporadic isolation of Sabin-like polioviruses and high-level detection of non-polio enteroviruses during sewage surveillance in seven Italian cities, after several years of inactivated poliovirus vaccination. Appl Environ Microbiol. 2014;80:4491&#8211;501.</td><td><a href=http://dx.doi.org/10.1128/AEM.00108-14>10.1128/AEM.00108-14</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Hovi T, Shulman L, Van der Avoort H, Deshpande J, Roivainen M, DE Gourville EM. Role of environmental poliovirus surveillance in global polio eradication and beyond. Epidemiol Infect. 2012;1:1&#8211;13.</td><td><a href=http://dx.doi.org/10.1017/S095026881000316X>10.1017/S095026881000316X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Sutter RW, Platt L, Mach O, Jafari H, Aylward RB. The new polio eradication end game: rationale and supporting evidence. J Infect Dis. 2014;210 Suppl 1:S434&#8211;8.</td><td><a href=http://dx.doi.org/10.1093/infdis/jiu222>10.1093/infdis/jiu222</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR48</td><td>BibChapter</td><td>Plotkin S, Murdin A, Vidor E. Inactivated poliovirus vaccine. In: Plotkin S, Orenstein W, editors. Vaccines. 3rd ed. 1999. p. 364&#8211;408.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. J Infect Dis. 1991;163:1&#8211;6.</td><td><a href=http://dx.doi.org/10.1093/infdis/163.1.1>10.1093/infdis/163.1.1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Fiore L, Plebani A, Buttinelli G, Fiore S, Donati V, Marturano J, et al. Search for poliovirus long-term excretors among patients affected by agammaglobulinemia. Clin Immunol. 2004;111:98&#8211;102.</td><td><a href=http://dx.doi.org/10.1016/j.clim.2003.11.011>10.1016/j.clim.2003.11.011</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>